Rates of Infection and Bleeding Are Not Increased in Patients with Myelodysplastic Syndromes (MDS) Treated with Azacitidine Compared with Supportive Care.
暂无分享,去创建一个
R. Larson | B. Peterson | L. Silverman | J. Backstrom | R. Odchimar-Reissig | D. McKenzie | Randy Hinkle